Business Wire | Jul 14, 2021 08:02AM EDT

Schrdinger to Present at Two Virtual Investor Conferences in July

Jul. 14, 2021

NEW YORK--(BUSINESS WIRE)--Jul. 14, 2021--Schrdinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will present at two investor conferences in July. On Tuesday, July 20, 2021, Schrdinger will provide a corporate overview at the Evercore ISI AI x Therapeutics Day. The presentation will take place virtually at 1:30 pm. ET.

Additionally, the company will present virtually at the SVB Leerink CybeRx: Big Data, A.I. & Machine Learning in Healthcare Conference on Wednesday, July 28, 2021, at 2:00 p.m. ET.

About Schrdinger

Schrdinger is transforming the way therapeutics and materials are discovered. Schrdinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrdinger's multidisciplinary drug discovery team also leverages the software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

Founded in 1990, Schrdinger has over 450 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com and follow us on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210714005242/en/

CONTACT: Jaren Irene Madden Schrdinger, Inc. jaren.madden@schrodinger.com 617-286-6264 Tracy Lessor Schrdinger, Inc. tracy.lessor@schrodinger.com 617-519-9827